Site Announcement
For the latest results and update on CytoDyn’s Phase 2 CRC trial and more, here’s a link to our April 30, 2026 investor update webinar
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 07/26/19 | SC TO-I/A | Issuer tender offer statement |
|
3 | |
| 07/26/19 | 8-K | Current report filing |
|
3 | |
| 07/25/19 | SC TO-I/A | Issuer tender offer statement |
|
6 | |
| 07/19/19 | SC TO-I/A | Issuer tender offer statement |
|
3 | |
| 07/19/19 | 8-K | Current report filing |
|
21 | |
| 07/15/19 | 424B3 | Prospectus filed pursuant to Rule 424(b)(3) |
|
2 | |
| 06/24/19 | SC TO-I | Issuer tender offer statement |
|
59 | |
| 06/19/19 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 06/19/19 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 06/19/19 | 4 | Statement of changes in beneficial ownership of securities |
|
1 |
